Neonatal alloimmune thrombocytopenia: pathogenesis, diagnosis and management
- PMID: 23384054
- PMCID: PMC3895911
- DOI: 10.1111/bjh.12235
Neonatal alloimmune thrombocytopenia: pathogenesis, diagnosis and management
Abstract
Neonatal alloimmune thrombocytopenia, (NAIT) is caused by maternal antibodies raised against alloantigens carried on fetal platelets. Although many cases are mild, NAIT is a significant cause of morbidity and mortality in newborns and is the most common cause of intracranial haemorrhage in full-term infants. In this report, we review the pathogenesis, clinical presentation, laboratory diagnosis and prenatal and post-natal management of NAIT and highlight areas of controversy that deserve the attention of clinical and laboratory investigators.
© 2013 Blackwell Publishing Ltd.
Figures
References
-
- Arinsburg SA, Shaz BH, Westhoff C, Cushing MM. Determination of human platelet antigen typing by molecular methods: importance in diagnosis and early treatment of neonatal alloimmune thrombocytopenia. American Journal of Hematology. 2012;87:525–528. - PubMed
-
- Arnold DM, Smith JW, Kelton JG. Diagnosis and management of neonatal alloimmune thrombocytopenia. Transfusion Medicine Reviews. 2008;22:255–267. - PubMed
-
- Aster RH, Newman PJ. HPA-1a/b (PlA1/A2, Zwa/b): the odyssey of an alloantigen system. Immunohematology. 2007;23:2–8. - PubMed
-
- Bakchoul T, Kubiak S, Krautwurst A, Roderfeld M, Siebert HC, Bein G, Sachs UJ, Santoso S. Low-avidity anti-HPA-1a alloantibodies are capable of antigen-positive platelet destruction in the NOD/SCID mouse model of alloimmune thrombocytopenia. Transfusion. 2011;51:2455–2461. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
